title: Tofacitinib (Xeljanz) for rheumatoid arthritis.
mesh_terms: D000818:Animals; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000201:enzymology; D006801:Humans; D053616:Janus Kinase 3 / Q000037:antagonists & inhibitors / Q000378:metabolism; D010880:Piperidines; D011743:Pyrimidines / Q000493:pharmacokinetics / Q000627:therapeutic use*; D011758:Pyrroles / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic / Q000379:methods
chemical_list: D010880:Piperidines; D011743:Pyrimidines; D011758:Pyrroles; C479163:tofacitinib; C507933:JAK3 protein, human; D053616:Janus Kinase 3